Moussab Damlaj

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Sickle Cell Disease

Acute Myeloid Leukemia

Hematopoietic Stem Cell

Iron Deficiency

Top Venues

Bone marrow transplantation

Critical care research and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Moussab Damlaj, Mohamed Tlayjeh, Ahmad Damlaj, Bader Alahmari, Husam AlSadi, Mazin Ahmed, Zied AlJubour, Ayman Alhejazi, Hend Salama, Ayman Ibrahim, Abdulrahman Al Raizah, Mohammed Bakkar, Abdulraouf Ghori, Abdullah S Al Saleh, Ahmed S Al Askar, Mohsen Al Zahrani
Contemporary outcomes of high risk relapsed refractory classical hodgkin lymphoma patients-role of maintenance therapy in the real world. Bone marrow transplantation (2023)
Moussab Damlaj, Bader Alahmari, Ahmed S Al Askar, Ayman Alhejazi, Husam Alsadi, Inaam Shehab-Eddine, Abdulrahman Alghamdi, Walid Almashaqbeh, Heba Alshobaki, Isam Mahasneh, Ashwaq Alotaibi, Tahany Alanazi, Maybelle Balili, Mohammed Quarshi, Mazin Ahmed, Mohsen Al Zahrani
Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease. Bone marrow transplantation 57 (2) (2022)
Abdullah S Al Saleh, Abdulrahman I Alghamdi, Mohsen Al Zahrani, Bader Alahmari, Ayman Alhejazi, Ahmed S Al Askar, Husam Alsadi, Suha Alkhraisat, Inaam Shehab-Eddine, Moussab Damlaj
Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis. Bone marrow transplantation 57 (7) (2022)
Saeed Arabi, Abdullah O Almahayni, Abdulrahman A Alomair, Emad M Masuadi, Moussab Damlaj, Hasan M Al-Dorzi
Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study. Critical care research and practice 2021 (2021)
Khadega A Abuelgasim, Moussab Damlaj, Mohammad Bosaeed, Sumayyah Altamimi, Hind Abdullah, Reem M Ramli, Rahma Alzahrani, Nourah Alzughaibi, Bader Alahmari, Ayman Alhejazi, Ahmed S Al Askar, Mohsen Al Zahrani
Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation. Bone marrow transplantation 56 (12) (2021)
Mohsen Al Zahrani, Moussab Damlaj, Mohammed F Essa, Bader Alahmari, Ahmed S Al Askar, Ayman Hejazi, Enas Basher, Husam Alsadi, Mazin Ahmed, Rodaina Abujoub, Samer Ghazi, Heba Alshobaki, Khadega A Abuelgasim, Hind Salama, Giamal Gmati, Abdulrahman Alsultan
HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome. Bone marrow transplantation (2021)
Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K Al-Khabori, Mohsen Al Zahrani, Ahmad Alhuraiji, Abdulaziz Hamadah, Naif I AlJohani, Bader Alahmari, Mohammed F Essa, Ibraheem H Motabi, Imran K Tailor, Reem S Almaghrabi, Khalil Al-Farsi, Ibraheem Abosoudah, Mouhab F Ayas, Tusneem A Elhassan, Ashraf M Suhebeh, Syed Osman Ahmed, Saud Alhayli, Panayotis Kaloyannidis, Ahmad Alsaeed, Khalid Al Anezi, Sameer Alamoudi, Moussab Damlaj, Hani Al Hashmi, Mahmoud Aljurf
Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East. Bone marrow transplantation 56 (9) (2021)
Moussab Damlaj, Khadega A Abuelgasim, Ayman Alhejazi, Bader Alahmari, Ahmed S Al Askar, Mohsen Alzahrani
Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma. Bone marrow transplantation 55 (12) (2020)
Moussab Damlaj, Ahmed S Al Askar, Samer Ghazi, Bader Alahmari, Ayman Alhejazi, Mohsen Al-Zahrani
Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective. Bone marrow transplantation 53 (10) (2018)